(1)
Fadhil, H. R. .; Al-Jumaili, A. A.; Al-Ani, N. A. . Cost-Effectiveness Analysis of Reference Infliximab (Remicade) Compared to Its Biosimilar (Remsima) in Iraqi Patients With Rheumatoid Arthritis (Conference Paper )#. Iraqi Journal of Pharmaceutical Sciences 2023, 31 (Suppl.), 100-110. https://doi.org/10.31351/vol31issSuppl.pp100-110.